News & Trends - Pharmaceuticals
Target acquired: Merck and Omico set sights on fast-tracking precision cancer trials
Josie Downey, Managing Director of Merck Healthcare ANZ, and Professor David Thomas, Chief Science and Strategy Officer at Omico, unpack […]
MoreNews & Trends - MedTech & Diagnostics
Pressure pays off – for now: Health insurers to boost private hospital payouts
Private hospitals have welcomed a shift by health insurers to return more of the premium revenue to patients and providers, […]
MoreNews & Trends - Biotechnology
QBiotics reports promising data in rare cancer trial
On Rare Cancers Awareness Day (26 June), Australian biotech QBiotics Group unveiled the final efficacy and safety results from stage […]
MoreDigital & Innovation
Cracking the 60% problem: AI tailors chemotherapy dosing for Aussies with bowel cancer
University of Melbourne and Western Health researchers have pioneered an innovative artificial intelligence (AI) tool aimed at preventing inaccuracies in […]
MoreLeadership & Management
Medicines Australia taps cultural strategist to lead communications amid HTA reform push
Medicines Australia has appointed Rachael Coghlan as its new Communications Director, adding to its Executive Team as the organisation ramps […]
MoreESG
Breaking barriers, building futures: NACCHO and Sanofi fuel Indigenous pharmacy leadership
NACCHO and Sanofi Australia have unveiled the 2025 recipients of the Aboriginal and Torres Strait Islander Pharmacist Scholarship. This scholarship […]
MoreHuman Resources
BMS among leading pharma companies recognised at LGBTQ+ national awards
Pharmaceutical companies are among those leading the charge in workplace inclusion, with Bristol Myers Squibb (BMS), AstraZeneca, AbbVie and Gilead […]
MoreMedical and Science
Calls grow for Australia to unlock global R&D access
Research Australia and Universities Australia are amplifying calls for the government to commit to Horizon Europe, a move requiring significant […]
MoreCommunication
Mastering the art of saying ‘No’ to protect your career and well-being: Psychologist
As the year draws to a close, professionals and leaders alike are faced with increasing pressure to meet deadlines, complete […]
MoreMarketing & Strategy
Bayer, MSD and Takeda among winners at Asia Pacific awards
Bayer, MSD, Takeda, Alcon, and Cipla emerge as winners among this week’s announcements of Asia Pacific awards which celebrate organisations […]
MoreLatest News in Pharma, MedTech, Diagnostics & Biotech
Target acquired: Merck and Omico set sights on fast-tracking precision cancer trials
June 26, 2025
in News & Trends - Pharmaceuticals
Diagnosing the system, not just the patient: A rare alliance calls for reform
June 26, 2025
in News & Trends - Pharmaceuticals
QBiotics reports promising data in rare cancer trial
June 26, 2025
in News & Trends - Biotechnology
Pressure pays off – for now: Health insurers to boost private hospital payouts
June 25, 2025
in News & Trends - MedTech & Diagnostics
The push to script a new chapter for biosimilars
June 25, 2025
in News & Trends - Pharmaceuticals
Productivity Commission tears down flawed mental health agreement
June 25, 2025
in News & Trends - Pharmaceuticals
NSW health budget fails to deliver for patients
June 25, 2025
in News & Trends - MedTech & Diagnostics
AusBiotech champions Australia’s momentum in the global life sciences race
June 24, 2025
in News & Trends - Biotechnology
Breaking barriers, building futures: NACCHO and Sanofi fuel Indigenous pharmacy leadership
June 24, 2025
in ESG
When hearts and kidneys align: A united voice reshaping patient care
June 24, 2025
in News & Trends - MedTech & Diagnostics
PBS expansion puts life-changing cystic fibrosis treatment within reach for most patients
June 24, 2025
in News & Trends - Pharmaceuticals
Lab coats and ceilings: Amgen and ACRF join forces to break barriers for women in cancer research
June 23, 2025
in News & Trends - Pharmaceuticals
PBAC backs funding of novel therapies from AstraZeneca, BMS, Roche, Amgen, UCB and Organon
June 23, 2025
in News & Trends - Pharmaceuticals
PBAC greenlights broader access to Boehringer SGLT2i in landmark CKD recommendation
June 23, 2025
in News & Trends - Pharmaceuticals
Lilly’s oral GLP-1 agonist gains ground on injectables
June 23, 2025
in News & Trends - Pharmaceuticals
RACS welcomes report but challenges claim of excessive fees
June 23, 2025
in News & Trends - MedTech & Diagnostics
Local biotech earns green light to manufacture next-gen cell therapies
June 23, 2025
in News & Trends - Biotechnology
Game-changing Australian trial reshapes outcomes for lymphoma patients
June 20, 2025
in News & Trends - Pharmaceuticals
Cracking the 60% problem: AI tailors chemotherapy dosing for Aussies with bowel cancer
June 20, 2025
in Digital & Innovation
Follow Us
Partner with us
News & Trends - Pharmaceuticals
Target acquired: Merck and Omico set sights on fast-tracking precision cancer trials
Josie Downey, Managing Director of Merck Healthcare ANZ, and Professor David Thomas, Chief Science and Strategy Officer at Omico, unpack […]
MoreNews & Trends - Pharmaceuticals
Diagnosing the system, not just the patient: A rare alliance calls for reform
On Rare Cancers Awareness Day (26 June), Christine Cockburn, CEO of Rare Cancers Australia (RCA), and Paul Fenton, CEO of […]
MoreNews & Trends - Biotechnology
QBiotics reports promising data in rare cancer trial
On Rare Cancers Awareness Day (26 June), Australian biotech QBiotics Group unveiled the final efficacy and safety results from stage […]
MoreNews & Trends - MedTech & Diagnostics
Pressure pays off – for now: Health insurers to boost private hospital payouts
Private hospitals have welcomed a shift by health insurers to return more of the premium revenue to patients and providers, […]
More